Lingzhi Gong

Prof. Lingzhi Gong

Guangzhou University of Chinese Medicine
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Biochemical Pharmacology
Verified
Journal Article
Closed access
HLHong Li
Hong Li
YZYing Zhang
Ying Zhang
YGYajuan Guo
Yajuan Guo
RLRong Liu
Rong Liu
QYQi Yu
Qi Yu
CWCaiyan Wang
Caiyan Wang

1 November 2020 in Clinica Chimica Acta
Verified
Journal Article
Closed access
ZHZhisheng Huang
Zhisheng Huang
ZHZhuoru He
Zhuoru He
YKYu Kong
Yu Kong
ZLZhongqiu Liu
Zhongqiu Liu
LGLingzhi Gong
Lingzhi Gong

31 March 2020 in Alcohol and Alcoholism
Verified
Journal Article
Closed access
XGXia Gong
Xia Gong
QZQisong Zhang
Qisong Zhang
YRYanjiao Ruan
Yanjiao Ruan
MHMing Hu
Ming Hu
ZLZhongqiu Liu
Zhongqiu Liu
LGLingzhi Gong
Lingzhi Gong
Aims: To investigate the effect of ethanol intake on the whole enterohepatic circulation (EHC) of bile acids (BAs) and, more importantly, on pharmacokinetics of irinotecan.Methods: The present study utilized a mouse model administered by gavage with 0 (control), 240 mg/100 g (30%, v/v) and 390 mg/100 g (50%, v/v) ethanol for 6 weeks, followed by BA profiles in the whole EHC (including liver, gallbladder, intestine and plasma) and colon using ultra-high performance liquid chromatography with tandem mass spectrometry analysis. Pharmacokinetic parameters of irinotecan were measured after administration of irinotecan (i.v. 5 mg/kg) on alcohol-treated mice.Results: The results showed that compared with the control group, concentrations of most free-BAs, total amount of the three main forms of BAs (free-BA, taurine-BA and glycine-BA) and total BAs (TBAs) in 50% ethanol intake group were significantly increased, which are mostly attributed to the augmentation of free-BAs and taurine-BAs. Additionally, the TBAs in liver and gallbladder and the BA pool were markedly increased in the 30% ethanol intake group. Importantly, ethanol intake upregulated the expression of BA-related enzymes (Cyp7a1, Cyp27a1, Cyp8b1 and Baat) and transporters (Bsep, Mrp2, P-gp and Asbt) and downregulated the expression of transporter Ntcp and nuclear receptor Fxr in the liver and ileum, respectively. Additionally, 50% ethanol intake caused fairly distinct liver injury. Furthermore, the AUC0–24 h of irinotecan and SN38 were significantly reduced but their clearance was significantly increased in the disrupted EHC of BA by 50% ethanol intake.Conclusions: The present study demonstrated that ethanol intake altered the expression of BA-related synthetases and transporters. The BA levels, especially the toxic BAs (chenodeoxycholic acid, deoxycholic acid and lithocholic acid), in the whole EHC were significantly increased by ethanol intake, which may provide a potential explanation to illuminate the pathogenesis of alcoholic liver injury. Most importantly, chronic ethanol consumption had a significant impact on the pharmacokinetics (AUC0–24 h and clearance) of irinotecan and SN38; hence colon cancer patients with chronic alcohol consumption treated with irinotecan deserve our close attention.

10 May 2021 in Proteomics
Verified
Journal Article
Closed access
PDF file
ZHZhuoru He
Zhuoru He
ZLZhongqiu Liu
Zhongqiu Liu
LGLingzhi Gong
Lingzhi Gong


22 January 2019 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
RLRong Liu
Rong Liu
YRYanjiao Ruan
Yanjiao Ruan
ZLZhongqiu Liu
Zhongqiu Liu
LGLingzhi Gong
Lingzhi Gong